AZTherapies, Inc. is a private, late-stage clinical biopharmaceutical company developing treatments for devastating neurological conditions. We are using an innovative, multi-modal approach that recognizes neuro-inflammation as a root cause of neuro-degeneration, leveraging the ability of cromolyn, a small molecule with a well-characterized safety profile, to shift the brain’s innate immune cells from a pro-inflammatory to neuroprotective state. We are advancing a pipeline of candidates in Alzheimer's Disease, amyotrophic lateral sclerosis (ALS) and post-ischemic stroke cognitive impairment.
Location: United States, Massachusetts, Boston
Member count: 11-50
Total raised: $53.6M
Founded date: 2011
Investors 3
| Date | Name | Website |
| - | Dolby Fami... | dolbyventu... |
| - | Cavendish ... | cavendishf... |
| 11.08.2022 | Black Gran... | blackgrani... |
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 02.10.2020 | Series C | $33.6M | - | finsmes.co... |
| 07.12.2015 | - | $20M | - | medcitynew... |
Mentions in press and media 7
| Date | Title | Description | Category | Author | Source |
| 02.10.2020 | AZTherapie... | AZTherapies, Inc., a Boston, M... | USA | - | finsmes.co... |
| 30.09.2020 | AZTherapie... | BOSTON, Sept. 29, 2020 (GLOBE ... | - | - | citybizlis... |
| 29.09.2020 | AZTherapie... | BOSTON, Sept. 29, 2020 (GLOBE ... | - | - | marketscre... |
| 17.10.2019 | After 13%... | → AstraZeneca-partnered Fren... | - | Kathy Wong | endpts.com... |
| 17.10.2019 | AZTherapie... | BOSTON, Oct. 17, 2019 (GLOBE N... | - | - | citybizlis... |
| 07.12.2015 | AZTherapie... | “Confronting two triggering ca... | - | - | medcitynew... |
| - | AZTherapie... | AZTherapies, a Massachusetts G... | - | - | medcitynew... |